Sheaff Brock Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sheaff Brock Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $217,813 - $255,625	-366 Closed	0 $0
Q4 2021 Jun 02, 2022	BUY	$543.48 - $670.97 $5,434 - $6,709	10 Added 2.81%	366 $231,000
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $193,478 - $238,865	356 New	356 $225,000
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $212,452 - $256,701	-390 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $192,394 - $251,128	390 New	390 $243,000
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $175,728 - $230,275	-490 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $64,707 - $75,600	-150 Reduced 23.44%	490 $219,000
Q2 2017 Aug 09, 2017	BUY	N/A	640	640 $314,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.